These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12044596)

  • 1. Observational analysis of feeding induced by Delta9-THC and anandamide.
    Williams CM; Kirkham TC
    Physiol Behav; 2002 Jun; 76(2):241-50. PubMed ID: 12044596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide.
    Järbe TU; Lamb RJ; Lin S; Makriyannis A
    Psychopharmacology (Berl); 2001 Aug; 156(4):369-80. PubMed ID: 11498713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats.
    Jamshidi N; Taylor DA
    Br J Pharmacol; 2001 Nov; 134(6):1151-4. PubMed ID: 11704633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716.
    Higgs S; Williams CM; Kirkham TC
    Psychopharmacology (Berl); 2003 Feb; 165(4):370-7. PubMed ID: 12447606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors.
    Williams CM; Kirkham TC
    Psychopharmacology (Berl); 1999 Apr; 143(3):315-7. PubMed ID: 10353436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics.
    Fernández-Ruiz JJ; Muñoz RM; Romero J; Villanua MA; Makriyannis A; Ramos JA
    Biochem Pharmacol; 1997 Jun; 53(12):1919-27. PubMed ID: 9256167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats.
    Di Marzo V; Berrendero F; Bisogno T; González S; Cavaliere P; Romero J; Cebeira M; Ramos JA; Fernández-Ruiz JJ
    J Neurochem; 2000 Apr; 74(4):1627-35. PubMed ID: 10737621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance.
    Mallet PE; Beninger RJ
    Life Sci; 1998; 62(26):2431-9. PubMed ID: 9651110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperphagia in pre-fed rats following oral delta9-THC.
    Williams CM; Rogers PJ; Kirkham TC
    Physiol Behav; 1998 Nov; 65(2):343-6. PubMed ID: 9855485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons.
    Romero J; García L; Cebeira M; Zadrozny D; Fernández-Ruiz JJ; Ramos JA
    Life Sci; 1995; 56(23-24):2033-40. PubMed ID: 7776829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function.
    Romero J; de Miguel R; García-Palomero E; Fernández-Ruiz JJ; Ramos JA
    Brain Res; 1995 Oct; 694(1-2):223-32. PubMed ID: 8974649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats.
    Smith FL; Fujimori K; Lowe J; Welch SP
    Pharmacol Biochem Behav; 1998 May; 60(1):183-91. PubMed ID: 9610941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol.
    Romero J; García L; Fernández-Ruiz JJ; Cebeira M; Ramos JA
    Pharmacol Biochem Behav; 1995 Aug; 51(4):731-7. PubMed ID: 7675852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical role of the endogenous cannabinoid system in mouse pup suckling and growth.
    Fride E; Ginzburg Y; Breuer A; Bisogno T; Di Marzo V; Mechoulam R
    Eur J Pharmacol; 2001 May; 419(2-3):207-14. PubMed ID: 11426843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of cannabimimetic discriminative stimulus effects of anandamide and methylated fluoroanandamide in rhesus monkeys.
    Wiley JL; Golden KM; Ryan WJ; Balster RL; Razdan RK; Martin BR
    Pharmacol Biochem Behav; 1997 Dec; 58(4):1139-43. PubMed ID: 9408225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride].
    Shivachar AC; Martin BR; Ellis EF
    Biochem Pharmacol; 1996 Mar; 51(5):669-76. PubMed ID: 8615904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cannabimimetic effects of structural analogs of anandamide in rats.
    Wiley JL; Ryan WJ; Razdan RK; Martin BR
    Eur J Pharmacol; 1998 Aug; 355(2-3):113-8. PubMed ID: 9760024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol.
    Kirkham TC; Williams CM; Fezza F; Di Marzo V
    Br J Pharmacol; 2002 Jun; 136(4):550-7. PubMed ID: 12055133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission.
    Hampson AJ; Bornheim LM; Scanziani M; Yost CS; Gray AT; Hansen BM; Leonoudakis DJ; Bickler PE
    J Neurochem; 1998 Feb; 70(2):671-6. PubMed ID: 9453561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances 'liking' of a sweet reward.
    Mahler SV; Smith KS; Berridge KC
    Neuropsychopharmacology; 2007 Nov; 32(11):2267-78. PubMed ID: 17406653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.